VCU Massey–Sanford Burnham Prebys Drug Discovery Collaborative Program launches two projects

Trump imposes up to 100% tariff on some brand name pharmaceutical companies

President Donald Trump has imposed a 100% tariff on drugmakers that have not struck a deal with the president to lower the U.S. drug prices of patented pharmaceutical products and ingredients.

April 03, 2026

Vol.52 No.13

By Claire Marie Porter

Clinical Roundup

Small molecule inhibitor blocks prostate cancer bone metastasis

Findings out of VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine, published in Pharmacological Research, show that a targeted small molecule inhibitor, IVMT-Rx-4, may prevent prostate tumors from spreading to an advanced and incurable stage in the bones.

April 03, 2026

Vol.52 No.13

In Brief

Lisa Roth named director of pediatric hematology-oncology at Hassenfeld Children’s Hospital at NYU Langone

Lisa G. Roth was named director of the Division of Pediatric Hematology-Oncology at Hassenfeld Children’s Hospital at NYU Langone and Perlmutter Cancer Center. Roth is a pediatric oncologist, physician-scientist, and lymphoma survivor.

March 27, 2026

Vol.52 No.12

Clinical Roundup

VCU Massey researchers lead international effort to produce multi-omic digital atlas of oral tissues

Researchers at VCU Massey Comprehensive Cancer Center led an international effort to create a multi-omic atlas of oral tissues with the aim of advancing the understanding of the immunoregulatory nature of human oral tissues. Recent analyses using data from this atlas suggest that fibroblasts may serve as the core regulators of structural immunity in the mouth.

March 27, 2026

Vol.52 No.12

Regulatory News

Prasad’s rule by fiat spilled into accelerated approvals in hematology and oncology
Atara Bio’s Cokey Nguyen: Normally, FDA wants to help us succeed. Now, “we’re getting new guidance at the last minute and it’s not helping.”

On Jan. 9, Pierre Fabre Pharmaceuticals received a “complete response letter” from FDA: its application for the T-cell therapy tabelecleucel (Ebvallo) was getting a hard No.

Researchers at VCU identify Achilles’ heel in lung cancer through common genetic mutation

A team of researchers at VCU Massey Comprehensive Cancer Center has identified a new pathway through which mutations in the tumor suppressor p53 gene—found very frequently in human tumors—hijack DNA replication in cancer cells.

March 13, 2026

Vol.52 No.10

VCU Massey–Sanford Burnham Prebys Drug Discovery Collaborative Program launches two projects

YOU MAY BE INTERESTED IN

Trump imposes up to 100% tariff on some brand name pharmaceutical companies

Small molecule inhibitor blocks prostate cancer bone metastasis

Lisa Roth named director of pediatric hematology-oncology at Hassenfeld Children’s Hospital at NYU Langone

VCU Massey researchers lead international effort to produce multi-omic digital atlas of oral tissues

Prasad’s rule by fiat spilled into accelerated approvals in hematology and oncology
Atara Bio’s Cokey Nguyen: Normally, FDA wants to help us succeed. Now, “we’re getting new guidance at the last minute and it’s not helping.”

Researchers at VCU identify Achilles’ heel in lung cancer through common genetic mutation

Renew today!

Subscriber content

Never miss an issue!

Login

VCU Massey–Sanford Burnham Prebys Drug Discovery Collaborative Program launches two projects

YOU MAY BE INTERESTED IN

Trump imposes up to 100% tariff on some brand name pharmaceutical companies

Small molecule inhibitor blocks prostate cancer bone metastasis

Lisa Roth named director of pediatric hematology-oncology at Hassenfeld Children’s Hospital at NYU Langone

VCU Massey researchers lead international effort to produce multi-omic digital atlas of oral tissues

Prasad’s rule by fiat spilled into accelerated approvals in hematology and oncologyAtara Bio’s Cokey Nguyen: Normally, FDA wants to help us succeed. Now, “we’re getting new guidance at the last minute and it’s not helping.”

Researchers at VCU identify Achilles’ heel in lung cancer through common genetic mutation

Never miss an issue!

Login

Prasad’s rule by fiat spilled into accelerated approvals in hematology and oncology
Atara Bio’s Cokey Nguyen: Normally, FDA wants to help us succeed. Now, “we’re getting new guidance at the last minute and it’s not helping.”